Please click here to see the latest news stories relating to Covid-19

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.


May 4th 2021

TCI presents Bioconjugation reagents to be used for example in drug discovery, ligand binding assays, disease diagnosis and high-throughput screening.

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project

Encouraging progress is being made towards vaccine development against Covid-19. It is essential that we continue to incentivise and fund research into and development of these technologies.

With direct-to-consumer genetic tests becoming more popular and governments looking to collect and utilise genetic data in clinical and research settings, it appears the amount of genetic da...

Arcis Biotechnology, the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pip...

ATMP (Advanced therapy medicinal product) specialist Cobra Biologics builds Sweden’s first 500 litre bioreactor investing €20 million at its Matfors facility in Sundsvall.

Agreement gives Iksuda access to Femtogenix’s therapeutic payloads to advance lead ADC for difficult-to-treat solid tumours

Arcis Biotechnology, the Sci- Tech Daresbury based company whose patented technology is focused on providing fast and convenient nucleic acid sample preparation solutions is now live for inv...

Cobra Biologics, an international CDMO of biologics and pharmaceuticals, announced that it has been awarded £2.6 million ($3.4 million) capital infrastructure investment by Innovate UK.

Our Valued Sponsors & Partners